These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39000138)

  • 1. Exploring the Efficacy of Peptides and Mimics against Influenza A Virus, Adenovirus, and Murine Norovirus.
    Urmi UL; Vijay AK; Willcox MDP; Attard S; Enninful G; Kumar N; Islam S; Kuppusamy R
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of an aqueous extract derived from Aloe arborescens Mill. against a broad panel of viruses causing infections of the upper respiratory tract.
    Glatthaar-Saalmüller B; Fal AM; Schönknecht K; Conrad F; Sievers H; Saalmüller A
    Phytomedicine; 2015 Sep; 22(10):911-20. PubMed ID: 26321740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus.
    Pinkenburg O; Meyer T; Bannert N; Norley S; Bolte K; Czudai-Matwich V; Herold S; Gessner A; Schnare M
    PLoS One; 2016; 11(6):e0156929. PubMed ID: 27273104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action.
    De Angelis M; Casciaro B; Genovese A; Brancaccio D; Marcocci ME; Novellino E; Carotenuto A; Palamara AT; Mangoni ML; Nencioni L
    FASEB J; 2021 Feb; 35(2):e21358. PubMed ID: 33538061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.
    Tripathi S; Wang G; White M; Qi L; Taubenberger J; Hartshorn KL
    PLoS One; 2015; 10(4):e0124706. PubMed ID: 25909853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.
    Smee DF; Hurst BL; Day CW
    Antivir Chem Chemother; 2012 Aug; 22(6):263-72. PubMed ID: 22516927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
    Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
    Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans.
    To KKW; Mok KY; Chan ASF; Cheung NN; Wang P; Lui YM; Chan JFW; Chen H; Chan KH; Kao RYT; Yuen KY
    J Gen Virol; 2016 Aug; 97(8):1807-1817. PubMed ID: 27259985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Reliable Multifaceted Solution against Foodborne Viral Infections: The Case of RiLK1 Decapeptide.
    Galatola E; Agrillo B; Gogliettino M; Palmieri G; Maccaroni S; Vicenza T; Proroga YTR; Mancusi A; Di Pasquale S; Suffredini E; Cozzi L
    Molecules; 2024 May; 29(10):. PubMed ID: 38792166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
    Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
    PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral effect of «Kagocel» substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.].
    Fediakina IT; Konopleva MV; Proshina ES; Linnik EV; Nikitina NI
    Vopr Virusol; 2019; 64(3):125-131. PubMed ID: 31622059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.
    Xiang D; Zheng Y; Duan W; Li X; Yin J; Shigdar S; O'Connor ML; Marappan M; Zhao X; Miao Y; Xiang B; Zheng C
    Int J Nanomedicine; 2013; 8():4103-13. PubMed ID: 24204140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
    Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
    Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porous gold nanoparticles for attenuating infectivity of influenza A virus.
    Kim J; Yeom M; Lee T; Kim HO; Na W; Kang A; Lim JW; Park G; Park C; Song D; Haam S
    J Nanobiotechnology; 2020 Mar; 18(1):54. PubMed ID: 32209114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
    Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL
    J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
    Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.